ZENYX® Tirzepatide acts simultaneously on GIP and GLP-1 receptors, promoting metabolic regulation, appetite control, and satiety. Each pen contains 90 mg in 3 ml of sterile solution with a 300-click dial-a-dose system.
Benefits
Each prefilled Zenyx® Tirzepatide pen contains 3 ml of sterile solution, providing 5 full doses of 0.6 ml. A dual GIP and GLP-1 receptor agonist.
Administered once weekly. Start with the lowest dose to minimize gastrointestinal effects and increase progressively under professional guidance.
⚠ Do not exceed 60 clicks in any 7-day period.
Do not use Zenyx® Tirzepatide in case of allergy to tirzepatide, or a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Like any medication, it may cause side effects — predominantly gastrointestinal and transient. In case of pancreatitis or a severe allergic reaction, seek immediate medical attention.
Before first use: 2 °C – 8 °C (refrigerated).
After first use: below 25 °C.
